Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

Completed

Conditions studied: Peripheral T-cell Lymphoma

In brief

Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.

Key facts

Study ID

NCT01110733

Run by

Acrotech Biopharma Inc.

People needed

3000

Starts

2010-02-01

Expected to finish

2019-12-01

Last updated by the study team

2020-01-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is newly diagnosed with Peripheral T-cell Lymphoma (PTCL):
• Aggressive natural killer (NK)-cell leukemia
• Adult T-cell lymphoma/leukemia (human T-cell leukemia virus [HTLV] 1+)
• Angioimmunoblastic T-cell lymphoma
• Anaplastic large cell lymphoma (ALCL), primary systemic type (ALK+, ALK-)
• PTCL, not otherwise specified (NOS)
• T/NK-cell lymphoma, nasal type
• Enteropathy-type intestinal lymphoma
• Hepatosplenic T-cell lymphoma
• Subcutaneous panniculitis T-cell lymphoma
• Transformed mycosis fungoides (at diagnosis of transformation)
• T-cell prolymphocytic leukemia (T-PLL)
• Cutaneous gamma/delta (γ/δ) T-cell lymphoma
• Cutaneous aggressive CD8+ T-cell lymphoma
• Hematodermic neoplasms (blastic plasmacytoid dendritic cell neoplasm)
• Systemic Epstein Barr Virus (EBV)+ T-cell lymphomas (T-cell lymphoproliferative disorders of childhood)
• Other T-Cell lymphomas that are not listed in the Exclusion Criteria
• Patient gives written informed consent

You may not qualify if…

• Patient has other T- or NK-cell malignancies including:
• Precursor T/NK neoplasms
• T-cell large granular lymphocytic leukemia
• Mycosis fungoides, other than transformed mycosis fungoides
• Sézary syndrome
• Primary cutaneous CD30+ disorders: ALCL and lymphomatoid papulosis

Where it is running

• Arizona Cancer Center — Tucson, Arizona, United States
• Genesis Cancer Center — Hot Springs, Arkansas, United States
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• City of Hope National Medical Center — Duarte, California, United States
• Moores Cancer Center UCSD — La Jolla, California, United States
• Wilshire Oncology Medical Group — La Verne, California, United States
• UCLA — Los Angeles, California, United States
• USC & Norris Cancer Center — Los Angeles, California, United States
• Stanford University Medical Center — Stanford, California, United States
• UCLA Olive View Medical Center — Sylmar, California, United States
• Danbury Hospital Praxair Cancer Center — Danbury, Connecticut, United States
• Yale University School of Medicine — New Haven, Connecticut, United States
• Washington Cancer Institute at Washington Hospital Center — Washington D.C., District of Columbia, United States
• Georgetown University — Washington D.C., District of Columbia, United States
• Coral Springs Oncology — Coral Springs, Florida, United States
• Medical Specialists of the Palm Beaches — Lake Worth, Florida, United States
• Hematology Oncology Associates — Loxahatchee Groves, Florida, United States
• University of Miami — Miami, Florida, United States
• MD Anderson Orlando — Orlando, Florida, United States
• Moffit Cancer Center — Tampa, Florida, United States
• Emory University Cancer Center — Atlanta, Georgia, United States
• Georgia Cancer Specialists — Atlanta, Georgia, United States
• Medical College of Georgia — Augusta, Georgia, United States
• Kootenai Cancer Center — Post Falls, Idaho, United States
• DCH Cancer Treatment Center — Tuscaloosa, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.